139 related articles for article (PubMed ID: 12661752)
1. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea.
Bukhalo M; Zeitouni NC; Cheney RT
Cutis; 2003 Mar; 71(3):235-8. PubMed ID: 12661752
[TBL] [Abstract][Full Text] [Related]
2. A case of glyburide-induced leukocytoclastic vasculitis.
Henley JK; Blackmon JA; Fraga GR; Rajpara A; Maz M
Dermatol Online J; 2013 Sep; 19(9):19619. PubMed ID: 24050293
[TBL] [Abstract][Full Text] [Related]
3. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
4. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
5. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
6. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
Carlsen SM
Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
[TBL] [Abstract][Full Text] [Related]
7. [Case of hypersensitivity to sulfonylurea compounds].
Batko B
Wiad Lek; 1983 May; 36(9):761-3. PubMed ID: 6613126
[No Abstract] [Full Text] [Related]
8. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
[TBL] [Abstract][Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
10. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
Reinwein D
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
[No Abstract] [Full Text] [Related]
11. [Eruption of purpura compatible with vasculitis and torasemide].
Sanfélix Genovés J; Benlloch Nieto H; Verdú Tárraga R; Costa Alcaraz AM
Aten Primaria; 1998 Mar; 21(4):252-3. PubMed ID: 9607256
[No Abstract] [Full Text] [Related]
12. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
13. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
Brogard JM; Kuntzmann F; Touitou D; Dorner M
Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498
[No Abstract] [Full Text] [Related]
14. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
[No Abstract] [Full Text] [Related]
15. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
16. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
[TBL] [Abstract][Full Text] [Related]
17. Vasculitis with acute kidney failure and torasemide.
Palop-Larrea V; Sancho-Calabuig A; Gorriz-Teruel JL; Martínez-Mir I; Pallardó-Mateu LM
Lancet; 1998 Dec; 352(9144):1909-10. PubMed ID: 9863798
[No Abstract] [Full Text] [Related]
18. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
20. Actual problems of the hypoglycaemic sulfonylureas.
Káldor A
Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
